What are the toxic levels of Lexapro (escitalopram)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Toxic Levels of Lexapro (Escitalopram)

There is no established specific toxic blood level for escitalopram, but overdoses can cause serious cardiac complications including QT prolongation, wide complex tachyarrhythmias, and torsade de pointes, as well as seizures and altered mental status including coma. 1

Clinical Manifestations of Escitalopram Toxicity

Escitalopram overdose can present with several concerning clinical manifestations:

Cardiovascular Effects

  • QRS and QTc interval prolongation
  • Wide complex tachyarrhythmias
  • Torsade de pointes
  • Hypertension (most common)
  • Rarely hypotension, especially with co-ingestants including alcohol 1

Neurological Effects

  • Seizures (which may be delayed)
  • Altered mental status including coma 1
  • Serotonin syndrome (especially with multiple proserotonergic drug ingestion) 2

Comparative Toxicity

Escitalopram appears to be less toxic than its racemic parent compound citalopram in overdose:

  • In a comparative study of 374 citalopram and 421 escitalopram overdoses, more serious outcomes were associated with citalopram overdoses (p<0.001)
  • Seizures were significantly more common with citalopram than escitalopram (30 vs. 1, p<0.001)
  • QTc prolongation occurred in 14 citalopram cases and 7 escitalopram cases (p=0.109) 3

Case Reports of Fatal Overdoses

A case report documented a fatal overdose involving escitalopram with blood concentration of 65.5 mg/L, in combination with mirtazapine (20.3 mg/L) and valproic acid (417 mg/L) 4. This suggests that high blood concentrations in the range of 65 mg/L may be potentially lethal, especially when combined with other medications.

Management of Escitalopram Overdose

For patients with suspected escitalopram overdose:

  1. Cardiac monitoring is essential:

    • Prolonged cardiac monitoring is recommended due to arrhythmia risk 1
    • Monitor for QT prolongation and arrhythmias
  2. Gastrointestinal decontamination:

    • Consider activated charcoal for patients who present early after overdose 1
    • For pediatric patients, use non-sorbitol containing activated charcoal products 5
  3. Supportive care:

    • Establish an open airway and provide ventilatory support as needed 5
    • Monitor for seizures and have anticonvulsant therapy available
  4. Antidote considerations:

    • No specific antidote exists for escitalopram toxicity
    • Flumazenil should be avoided in mixed overdoses involving escitalopram due to risk of seizures 5
  5. Expert consultation:

    • Contact a poison center (1-800-222-1222) or medical toxicologist for overdose management recommendations 1

Special Considerations

  • Dose-response relationship: There is an association between increasing dose and severity of outcome for escitalopram (p=0.011) 3
  • Pediatric patients: In children under 6 years old, even small ingestions can cause toxicity including drowsiness, nausea/vomiting, and tachycardia 3
  • Drug interactions: Risk of serotonin syndrome is increased when combined with other serotonergic medications 2

Conclusion

While there is no established specific toxic blood level for escitalopram, clinical toxicity can manifest with serious cardiac complications, seizures, and altered mental status. Prompt recognition and management of these complications, along with supportive care and expert consultation, are essential for optimal outcomes in escitalopram overdose.

References

Research

Serotonin syndrome in a patient taking Lexapro and Flexeril: a case report.

The American journal of emergency medicine, 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.